Cancer treatments, such as chemotherapy and targeted therapies, can act as selective pressures that shape the evolution of cancer. While these therapies may initially reduce the tumor burden, they can also lead to the emergence of resistant clones. This phenomenon is known as therapeutic resistance. Understanding the mechanisms behind resistance can help in developing combination therapies and adaptive treatment strategies to outsmart evolving cancer cells.
